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Abstract Ubiquinol is an endogenously synthesized lipid-soluble
antioxidant. Regeneration of ubiquinol from the oxidized form is
essential to the maintenance of its antioxidant function. We
demonstrated that lipoamide dehydrogenase can reduce ubiqui-
none to ubiquinol. Zinc increased the rate of the NADPH-
dependent reduction more than 10-fold. The concentration
ubiquinone resulting in the half-maximal rate of reduction was
approximately 5 WM in the presence and 4 WM in the absence of
zinc. These data may explain how ubiquinone is reduced to the
active antioxidant ubiquinol, which plays such an important role
in protecting against oxidative stress and lipid peroxidation.
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1. Introduction
Reactive oxygen species (ROS) can cause oxidative damage
to living cells due to their high level of reactivity. The poly-
unsaturated fatty acids in biological membranes are particu-
larly sensitive to oxidative damage by ROS. Reaction of these
species with unsaturated fatty acids initiates a chain-reaction
leading to extensive damage to the membrane, a process
known as lipid peroxidation [1]. This process can be prevented
by lipid-soluble antioxidants such as vitamin E (K-tocopherol)
and ubiquinol [1], which function as antioxidants only in the
reduced state. Therefore, when tocopherol and ubiquinol are
oxidized by ROS their reduced forms must be regenerated.
Ubiquinone (Q10) is an obligatory participant in the mito-
chondrial respiratory chain, where it is present in large excess
over the other components involved in electron transport in
order to achieve maximal respiration [2]. In recent years ubiq-
uinol (reduced Q10) has been the object of renewed interest,
since accumulating evidence indicates that this substance is
our only endogenously synthesized lipid-soluble antioxidant
and is present in all membranes [1,3^5]. The mechanism by
which Q10 is reduced to ubiquinol is not known although
di¡erent cytosolic enzymes have been proposed to be involved
[6,7]. However, no speci¢c enzyme catalyzing this reaction has
been identi¢ed and therefore, we have investigated the well-
known enzyme, lipoamide dehydrogenase (EC 1.8.1.4), in this
regard.
Lipoamide dehydrogenase is a component of the 3-K-keto-
acid dehydrogenase complex which oxidizes pyruvate, K-keto-
glutarate and the branched-chain K-ketoacids. This enzyme
complex is present at the matrix surface of the inner mito-
chondrial membrane in all eukaryotic organisms studied to
date. It catalyzes the oxidative decarboxylation of pyruvate
with concomitant formation of CO2, acetyl-CoA and
NADH. In this complex (dihydro)lipoamide dehydrogenase
catalyzes NAD-dependent oxidation of the dihydrolipoyl co-
factor covalently linked to the components catalyzing acetyl
transferase.
Lipoamide dehydrogenase belongs to a family of pyridine
nucleotide-disul¢de oxidoreductases [8], which are homodi-
meric proteins with subunits approximately 50 kDa in size,
each containing a FAD moiety and a redox-active disul¢de.
Lipoamide dehydrogenase is ubiquitous in aerobic organisms,
including prokaryotes, eukaryotes and archaebacteria. There
are certain indications that this enzyme is present not only in
the mitochondria, but also in plasma membranes ([9],
Bjoºrnstedt et al., in preparation). Lipoamide dehydrogenase
also reduces the low-molecular weight antioxidant thiols lip-
oamide and lipoic acid [8]. The latter has been proposed as
having bene¢cial e¡ects in the treatment of diseases of the
liver [10].
2. Materials and methods
2.1. Chemicals
Methanol; petroleum ether (b.p. 40^60‡C); 2-propanol and n-hex-
ane of analytical grade; CuSO4W5H2O; Na-K-tartrateW4H2O; NaOH;
Na2CO3 ; NaDOC and ZnCl2 were purchased from KEBO (Stock-
holm, Sweden). NADH, NADPH, EDTA, Trizma base and ubiqui-
none-6 and -10 were obtained from Sigma (St. Louis, MO, USA).
2.2. Enzyme preparation
Lipoamide dehydrogenase from porcine heart (type III; L2002) was
delivered by Sigma as a suspension in 3.2 M ammonium sulfate. This
suspension was centrifuged at 10 000 rpm for 5 min in Eppendorf
tubes, the supernatant discarded and the pellet dissolved in 50 mM
Tris-HCl, pH 7.5. Remaining ammonium sulfate was removed by
chromatography on a Sephadex G-25 column (NAP-5; Pharmacia,
Sweden). This column was pre-equilibrated with 50 mM Tris-HCl,
pH 7.5 and the protein was eluted using the same bu¡er. Protein
was quanti¢ed using the procedure of Lowry and coworkers [11]
and the solution then diluted to obtain 1 mg protein/ml. The activity
of the puri¢ed protein was measured as the oxidation of NADH
(spectrophotometrically at 340 nm) in the presence of lipoamide.
2.3. In vitro incubation with ubiquinone
The 100 Wl assay mixtures contained 50 mM Tris-HCl, pH 7.5,
1.0 mM EDTA, 0.1% Triton X-100, NADPH or NADH (1.6 mg/
ml) and up to 50 WM ubiquinone-10. Ubiquinone was dissolved in
ethanol, but the ¢nal content of ethanol in the mixtures did not
exceed 2% in any incubation. In some experiments ZnCl2 was added
to give a ¢nal concentration of 500 WM and in these experiments
EDTA was absent. The reaction was started by the addition of lip-
oamide dehydrogenase in di¡erent amounts up to 30 Wg. After the
addition of all components, the test tubes were £ushed with nitrogen,
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covered, vortexed and placed in a water bath at 37‡C for incubation
for the di¡erent time periods indicated. Reactions were terminated by
the addition of methanol.
2.4. Extraction procedure
Lipid extraction was performed according to a procedure described
previously [5], with certain modi¢cations. After incubation, 5 ml
methanol was added followed by 400 Wl distilled water and
0.68 nmol Q6 (as internal standard). Subsequently 3 ml petroleum
ether (b.p. 40^60‡C) was used to extract ubiquinone and ubiquinol.
To accomplish this the liquid phases were mixed by shaking and the
test-tubes then centrifuged at 1000 rpm for 3 min at room temper-
ature. The upper petroleum ether phase was removed and evaporated
under nitrogen. The residue was dissolved in 25 Wl methanol:n-hex-
ane:2-propanol, 2:1:1, and injected directly onto the HPLC column.
This entire procedure was completed within 10 min.
2.5. HPLC analysis
Ubiquinone and ubiquinol were quantitated by reversed-phase
HPLC (LC-6A, Shimadzu, Kyoto, Japan) using a Hewlett Packard
Hypersil ODS 3 Wm column. The solvents employed were: in pump
system A, methanol:water, 9:1 and in system B, methanol:2-propa-
nol:n-hexane, 2:1:1. Linear gradients from 10^50% solvent B were
run for 15 min, followed by 50^55% solvent B for 8 min, and, ¢nally,
55^100% solvent B for an additional 3 min, all at a £ow rate of 1.5 ml/
min. The temperature was maintained at 15‡C. Ubiquinone-6, ubiq-
uinol-10 and ubiquinone-10 were monitored with an UV-detector
(Shimadzu, L-ECD-6A), and eluted in three well-separated peaks
with retention times of 10^11, 19^20 and 25^26 min, respectively.
3. Results
The addition of ubiquinone to an incubation mixture con-
taining lipoamide dehydrogenase and NADH or NADPH re-
sulted in the reduction of this compound to ubiquinol. With
100 pmol enzyme, approximately 23 and 19 pmol of ubiqui-
none, respectively, was reduced per min. The rate of this re-
action was dependent on the amount of lipoamide dehydro-
genase present (Fig. 1) and the reaction showed an
exponential con¢guration.
Zinc is known to inhibit several members of the pyridine
nucleotide-disul¢de oxidoreductase family. Thus, the in£uence
of this cation on the reduction of ubiquinone by lipoamide
dehydrogenase, was examined. In this system the rate of the
NADPH-dependent reaction was increased more than 10-fold
(Fig. 2), whereas the rate of the NADH-dependent reaction
was not signi¢cantly altered by zinc. Other divalent cations
(Ca2, Mg2, Mn2) did not potentiate the rate of the reac-
tion (Xia et al., in preparation).
The concentration of ubiquinone resulting in half-maximal
rate of reduction (apparent Km) was approximately 5 WM with
and 4 WM without zinc (Fig. 3). Since the reaction rate in-
crease exponentially with increasing enzyme concentration, as
shown in Fig. 1, the turnover number (Kcat) has to be given at
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Fig. 1. Reduction of ubiquinone by di¡erent amounts of lipoamide
dehydrogenase (LipDH) using NADPH as co-factor. Enzyme (0^30
Wg) was added to 50 mM Tris-Cl, pH 7.5, containing Triton X-100,
NADPH and ubiqiunone (Q10). Ubiquinone and ubiquinol were ex-
tracted and analyzed by HPLC as described in Section 2. The val-
ues given are the means of three di¡erent experiments at each en-
zyme concentration indicated.
Fig. 2. Zinc-dependent potentiation of the reduction of ubiquinone
by lipoamide dehydrogenase (LipDH). Lipoamide dehydrogenase
(10 Wg), ubiquinone, NADPH and Triton X-100, were incubated for
20 min in the absence (light bars) or presence (dark bars) of zinc.
Ubiquinone and ubiquinol were extracted and analyzed by HPLC
as described in Section 2.
Fig. 3. Dependence of the reduction of ubiquinone (Q10) by lipo-
amide dehydrogenase on substrate concentration in the absence and
presence of zinc. The reactions were performed as described in the
legend to Fig. 1 except that increasing concentrations of ubiquinone
were employed. The concentration of ubiquinone giving the half-
maximal rate was approximately 5 WM with zinc (F) and 4 WM
without zinc (8) and the half-maximal rates were 115 and 10 pmol
Q10 reduced/min, respectively. The values given are the means of
three di¡erent experiments.
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a speci¢ed enzyme concentration. At the enzyme concentra-
tion used in these experiments (1 WM) the Kcat was approx-
imately 2.4 min31 in the presence and 0.2 min31 in the ab-
sence of zinc.
4. Discussion
This investigation clearly demonstrates that ubiquinone is
reduced to its active antioxidant form ubiquinol by lipoamide
dehydrogenase with either NADH or NADPH as the cofac-
tor. Furthermore, this reaction is potently stimulated by zinc,
but only when NADPH is the co-factor. This is especially
interesting in light of the fact that NAD(H) is the co-factor
generally employed in the extensive studies on lipoamide de-
hydrogenase in mitochondria.
Redox reactions of (dihydro)lipoamide involves the sulf-
hydryl groups in the active site of lipoamide dehydrogenase.
However, these reactions are e⁄ciently inhibited by zinc (Xia
et al., in preparation). The potent stimulation of the reduction
of ubiquinone by zinc suggests that di¡erent active sites on the
enzyme molecule may be involved in the two di¡erent reac-
tions. The site responsible for the reduction of ubiquinone
most likely contains the FAD moiety. The potent e¡ect of
zinc may involve a conformational change in lipoamide dehy-
drogenase and is now under further investigation at our labo-
ratory.
Located in the immediate vicinity of ubiquinone in the mi-
tochondria, lipoamide dehydrogenase is part of the pyruvate
dehydrogenase complex. This enzyme has also been detected
in the plasma membrane ([9], Bjoºrnstedt et al., in prepara-
tion). These localizations of ubiquinone and lipoamide dehy-
drogenase as well as the fact that ubiquinone is taken up by
cells [12], strongly support the physiological relevance of our
observations.
In cells constantly exposed to ROS, antioxidants play an
important role in preventing damage to biological membranes
from lipid peroxidation. Reduction of ubiquinone by lipo-
amide dehydrogenase and the strong potentiation of this
reaction by zinc may explain how levels of ubiquinol are
restored, forming an e⁄cient pathway (Fig. 4) for the elimi-
nation of ROS.
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Fig. 4. Schematic illustration of the reduction of ubiquinone by lipoamide dehydrogenase (LipDH) and the scavenging of ROS by ubiquinol.
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